NCRIS Health Group
Working together to keep Australians healthy through research innovation.
Health and medical researchers investigate solutions to complex problems that are often not easily solved by a single discipline. The NCRIS Health Group is aimed at enabling them collaboratively throughout the innovation and translational process.
Enabling Health Innovation and Translation
Health Group infrastructure
The Health Group offers seamless access to world class research infrastructure and expertise.
Governance
The NCRIS Health Group is a cross-capability collaboration established via a Collaboration Agreement. The Group is coordinated via a leadership group comprising the Board Chairs and Chief Executives of the ten member capabilities.
NCRIS Health Group Booklet
NCRIS Health Group Highlights

NCRIS Health Group: Improving Heart Health
NCRIS Health Group, Enabling health innovation and translation Together, we tackle complex, multidisciplinary medical challenges using world-class national research infrastructure. Our experts, data and tools shepherd

NCRIS Health Group: Advancing RNA treatments and vaccines
NCRIS Health Group, Enabling health innovation and translation Together, we tackle complex, multidisciplinary medical challenges using world-class national research infrastructure. Our experts, data and tools shepherd

NCRIS Health Group: Battling Bacteria
NCRIS Health Group, Enabling health innovation and translation Together, we tackle complex, multidisciplinary medical challenges using world-class national research infrastructure. Our experts, data and tools shepherd

NCRIS Health Group: Beating Cancers
NCRIS Health Group, Enabling health innovation and translation Together, we tackle complex, multidisciplinary medical challenges using world-class national research infrastructure. Our experts, data and tools shepherd

NCRIS Synthetic Biology Voucher Scheme 2026-27 (Round 2)
Through the National Collaborative Research Infrastructure Strategy (NCRIS) program, the Commonwealth committed $55M to Bioplatforms Australia in 2023 for a four-year program to provide a step change investment

Pipeline Accelerator 2025-26 (Round 2) successful recipients announced
Phenomics Australia in partnership with Therapeutic Innovation Australia (TIA), Bioplatforms Australia (BPA), and ANSTO’s National Deuteration Facility (NDF), is thrilled to announce the successful recipients of

Pipeline Accelerator 2025-26 (Round 1) successful recipients announced
Phenomics Australia in partnership with Therapeutic Innovation Australia (TIA), Bioplatforms Australia (BPA), and ANSTO’s National Deuteration Facility (NDF), is thrilled to announce the successful recipients of

Critical conversations and collaboration in Australian and European health research infrastructure
Phenomics Australia joins critical conversations about collaborative international research infrastructure at the 2025 Australian and European Health Research Infrastructure Symposium. The 2025 Australian & European Health

Pipeline Accelerator 2025-26 Round 1 Now Open
Applications for Pipeline Accelerator 2025-26 Round 1 vouchers are now open In this Pipeline Accelerator round, Phenomics Australia is partnering with TIA, ANSTO’s National Deuteration Facility
